Loading chat...
NY S07807
Bill
Status
11/12/2025
Primary Sponsor
Andrew Gounardes
Click for details
AI Summary
-
Expands the definition of "epinephrine device" beyond auto-injectors to include any FDA-approved epinephrine delivery device, including nasal sprays, used for emergency treatment of anaphylactic reactions
-
Updates terminology throughout the Public Health Law, Education Law, and Insurance Law to replace "epinephrine auto-injector" with the broader term "epinephrine device"
-
Maintains existing requirements for schools, camps, public assembly venues, and other eligible entities to store, maintain, and administer epinephrine devices for emergency allergic reactions
-
Preserves insurance coverage mandates requiring health insurers to cover medically necessary epinephrine devices with out-of-pocket costs capped at $100 annually
-
Applies existing training, liability protections, and authorization requirements to all forms of epinephrine devices, not just auto-injectors
Legislative Description
Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.
Last Action
SIGNED CHAP.502
11/12/2025